Sam Altman-Backed Retro Biosciences Raising $1 Billion to Extend Human Lifespan
Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
ENDPOINTS NEWS8d
With Sam Alt­man’s help, Retro Bio­sciences eyes $1B to ex­tend lifes­pan by 10 years
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
decrypt10d
Sam Altman's Worldcoin Surges After Trump Teases $500 Billion OpenAI Plan
The price of Worldcoin jumped Wednesday, leading the crypto market after OpenAI's $500 billion AI initiative was unveiled.
These are Sam Altman's predictions on how the world might change with AI
OpenAI CEO Sam Altman has made several predictions about where we're headed on AGI, superintelligence, agentic AI — and when we might get there.